Monday December 10, 2018

New biomarker for breast and prostate cancers found

0
//
Republish
Reprint

cancer-390322_640

New York : Researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers.

The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs that attack the most aggressive forms of cancer.

“Understanding and identifying biomarkers is a vital step toward cancer research and care,” said lead study author Michael Freeman from Cedars-Sinai Medical Centre in Los Angeles, California, US.

“New profiling strategies exemplified by this study will ultimately improve our ability to treat cancer patients,” Freeman noted.

The newly identified genetic biomarker – diaphanous- related formin-3 or DIAPH3 – participates in a protein interaction that makes cells rigid.

The study found that when this biomarker is lost or lowered, cells become “deformable,” squeezing through tissue spaces, causing disease growth or progression.

The study was published in the journal Scientific Reports.

(IANS)

 

 

Click here for reuse options!
Copyright 2015 NewsGram

Next Story

World’s Smallest Wearable Can Help in Preventing Skin Cancer

It also demonstrated the ability to measure white light exposure for seasonal depression, a mood disorder characterised by depression that occurs at the same time every year

0
cancer
World's smallest device to prevent skin cancer, mood disorder risk. Pixabay

Scientists have developed the world’s smallest wearable, battery-free device that can warn people of overexposure to ultraviolet rays (UV) — a leading factor for developing skin cancer.

Currently, people do not know how much UV light they are actually getting. The rugged and waterproof device interacts wirelessly with the phone and helps maintain an awareness and for skin cancer survivors.

Smaller than an M&M (colourful button-shaped chocolates) and thinner than a credit card, the device can optimise treatment of neonatal jaundice, skin diseases, seasonal affective disorder and reduce risk of sunburns and skin cancer.

Users can glue the device on to their hats, clip it to sunglasses or stick it on their nail and can simultaneously record up to three separate wavelengths of light.

It is always on yet never needs to be recharged.

“There is a critical need for technologies that can accurately measure and promote safe UV exposure at a personalised level in natural environments,” said Steve Xu, from Northwestern University in the US.

Cancer
Cancer Ribbon. Pixabay

“We hope people with information about their UV exposure will develop healthier habits when out in the sun,” said Xu.

There are no switches or interfaces to wear out, and it is completely sealed in a thin layer of transparent plastic, the researchers stated, in the paper published in the journal Science Translational Medicine.

Participants who mounted device on themselves recorded multiple forms of light exposure during outdoor activities, even in the water.

Also Read- First NASA Probe to Return Asteroid Sample Reaches Destination

The findings showed that it monitored therapeutic UV light in clinical phototherapy booths for psoriasis and atopic dermatitis (immune diseases) as well as blue light phototherapy for newborns with jaundice in the neonatal intensive care unit.

It also demonstrated the ability to measure white light exposure for seasonal depression, a mood disorder characterised by depression that occurs at the same time every year. (IANS)